Similar Articles
301 Inferior outcomes of liver transplantation for hepatocellular carcinoma during early-COVID-19 pandemic in the United States
302 Lipid metabolism of hepatocellular carcinoma impacts targeted therapy and immunotherapy
303 Comprehensive analysis of prognostic value and immunotherapy prospect of brain cytoplasmic RNA1 in hepatocellular carcinoma
304 Correlation between immune-related adverse events and long-term outcomes in pembrolizumab-treated patients with unresectable hepatocellular carcinoma: A retrospective study
305 Preoperative prediction of macrotrabecular-massive hepatocellular carcinoma through dynamic contrast-enhanced magnetic resonance imaging-based radiomics
306 Hepatocellular carcinoma: State of the art diagnostic imaging
307 Pain management in patients with hepatocellular carcinoma after transcatheter arterial chemoembolisation: A retrospective study
308 Adherence to guideline-directed hepatocellular carcinoma screening: A single-center US experience
309 Patients with hepatocellular carcinoma that die during the first year of liver transplantation have high blood sFasL concentrations
310 Possible mechanisms associated with immune escape and apoptosis on anti-hepatocellular carcinoma effect of Mu Ji Fang granules
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA